RPRX Annual ROE
11.57%
+11.14%+2590.70%
31 December 2023
Summary:
As of January 22, 2025, RPRX annual return on equity is 11.57%, with the most recent change of +11.14% (+2590.70%) on December 31, 2023. During the last 3 years, it has fallen by -0.59% (-4.85%). RPRX annual ROE is now -73.66% below its all-time high of 43.92%, reached on December 31, 2019.RPRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Quarterly ROE
11.56%
+4.70%+68.51%
30 September 2024
Summary:
As of January 22, 2025, RPRX quarterly return on equity is 11.56%, with the most recent change of +4.70% (+68.51%) on September 30, 2024. Over the past year, it has increased by +3.44% (+42.36%). RPRX quarterly ROE is now -69.95% below its all-time high of 38.47%, reached on December 31, 2019.RPRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2590.7% | +42.4% |
| 3 y3 years | -4.8% | +42.4% |
| 5 y5 years | -62.3% | - |
RPRX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2590.7% | -0.5% | +2652.4% |
| 5 y | 5-year | -73.7% | +2590.7% | -70.0% | +2652.4% |
| alltime | all time | -73.7% | +2590.7% | -70.0% | +2652.4% |
Royalty Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 11.56%(+68.5%) |
| June 2024 | - | 6.86%(-15.5%) |
| Mar 2024 | - | 8.12%(-30.1%) |
| Dec 2023 | 11.57%(+2590.7%) | 11.62%(+518.1%) |
| Sept 2023 | - | 1.88%(-26.3%) |
| June 2023 | - | 2.55%(-22.7%) |
| Mar 2023 | - | 3.30%(+685.7%) |
| Dec 2022 | 0.43% | 0.42%(-91.4%) |
| Sept 2022 | - | 4.91%(+8.6%) |
| June 2022 | - | 4.52%(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 5.90%(-3.3%) |
| Dec 2021 | 6.15%(-49.4%) | 6.10%(-21.6%) |
| Sept 2021 | - | 7.78%(-21.0%) |
| June 2021 | - | 9.85%(-6.6%) |
| Mar 2021 | - | 10.55%(-8.3%) |
| Dec 2020 | 12.16%(-72.3%) | 11.50%(-58.0%) |
| Sept 2020 | - | 27.38%(-11.6%) |
| June 2020 | - | 30.96%(-15.0%) |
| Mar 2020 | - | 36.44%(-5.3%) |
| Dec 2019 | 43.92%(+43.1%) | 38.47% |
| Dec 2018 | 30.70% | - |
FAQ
- What is Royalty Pharma annual return on equity?
- What is the all time high annual ROE for Royalty Pharma?
- What is Royalty Pharma annual ROE year-on-year change?
- What is Royalty Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Royalty Pharma?
- What is Royalty Pharma quarterly ROE year-on-year change?
What is Royalty Pharma annual return on equity?
The current annual ROE of RPRX is 11.57%
What is the all time high annual ROE for Royalty Pharma?
Royalty Pharma all-time high annual return on equity is 43.92%
What is Royalty Pharma annual ROE year-on-year change?
Over the past year, RPRX annual return on equity has changed by +11.14% (+2590.70%)
What is Royalty Pharma quarterly return on equity?
The current quarterly ROE of RPRX is 11.56%
What is the all time high quarterly ROE for Royalty Pharma?
Royalty Pharma all-time high quarterly return on equity is 38.47%
What is Royalty Pharma quarterly ROE year-on-year change?
Over the past year, RPRX quarterly return on equity has changed by +3.44% (+42.36%)